The Egyptian Drug Authority (EDA) operates the Egyptian Pharmacovigilance Center through its Pharmaceutical Vigilance General Administration.
Core official resources
- Report side effects — public reporting for medicine and vaccine adverse events and other regulated products.
- Pharmacovigilance guidance — current EDA regulatory guidance, including Good Pharmacovigilance Practice material and 2026 adverse-reaction reporting guidance.
- EDA contact routes — hotline and electronic reporting access.
Practical use
Use the EDA guidance library for company-system requirements and the reporting service for individual safety reports. The guidance catalogue should be checked for the current issue/version before implementing a local procedure.